CC
MIRM icon

Checkpoint Capital’s Mirum Pharmaceuticals MIRM Stock Holding History

Checkpoint Capital’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-362,193
Closed -$9.1M – 20
2024
Q1 		$9.1M Buy
362,193
+128,534
+55% +$3.53M 6.08% 6
2023
Q4 		$6.9M Buy
+233,659
New +$7.07M 4.18% 8

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Checkpoint Capital's MIRM Position: Q2 2024 in Review

Checkpoint Capital sold out of Mirum Pharmaceuticals (MIRM) in Q2 2024, closing a stake of 362,193 shares — an estimated $9.1M sold.

Checkpoint Capital first reported a position in MIRM in Q4 2023 and held it in 2 quarters. The position peaked at $9.1M in Q1 2024. 160 funds tracked by Wall St. Rank hold MIRM as of Q2 2024.

  • Checkpoint Capital reported no remaining Mirum Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Checkpoint Capital sold 362,193 Mirum Pharmaceuticals shares in Q2 2024, an estimated $9.1M.
  • Checkpoint Capital first reported a position in Mirum Pharmaceuticals in Q4 2023 and held it in 2 quarters.
  • Checkpoint Capital's Mirum Pharmaceuticals position peaked at $9.1M in Q1 2024.
  • 160 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2024.

Based on Checkpoint Capital's 13F filing for Q2 2024, filed 14 Aug 2024.